With the introduction of major new health insurance reforms in Illinois, patients are poised to experience significant changes in their access to and quality of health care services. The recently signed measures—House Bill 5395 and House Bill 2499—aim to correct some of the most contentious pra
In a crowded waiting room at a public health center in Cape Town, Shameema De La Cruz anxiously sits for hours, her daughter in need of medical attention. This scene captures the frustrations of many South Africans relying on the under-resourced public health system. The National Health Insurance
Medicare, the federal health insurance program for individuals aged 65 and older, is at a crossroads. With over 54 percent of beneficiaries now enrolled in Medicare Advantage (MA) plans, questions arise about the future of both MA and traditional Medicare. Healthcare policy expert Dr. J. Michael
In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the
The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating
Gender bias in medical research has deep historical roots and continues to impact the health outcomes of women today. By understanding this complex issue, we can appreciate the importance of inclusive research practices and explore the steps needed to create a healthcare system that serves everyone
